Skip to main content
. 2022 Jan 20;42(1):e00327-21. doi: 10.1128/MCB.00327-21

FIG 3.

FIG 3

AMPKα promoted myogenesis during skeletal muscle development. (A) Western blotting of p-AMPKα and AMPKα after AICAR treatment (n = 3). (B to D) Western blotting of myogenin and MyHC after AICAR treatment (n = 3). (E) Western blotting of p-AMPKα and AMPKα after compound C treatment (n = 3). (F to H) Western blotting of myogenin and MyHC after compound C treatment (n = 3). (I to K) Western blotting of p-AMPKα and AMPKα after AMPKα shRNA transfection (n = 3). (L) Relative mRNA expression of myogenin after AMPKα shRNA transfection (n = 3). (M and N) Western blotting of MyHC after AMPKα shRNA transfection (n = 3). *, P < 0.05; **, P < 0.01; ***, P < 0.001. Error bars indicate SD.